Cargando…

Unusually High Affinity of the PLK Inhibitors RO3280 and GSK461364 to HSA and Its Possible Pharmacokinetic Implications

[Image: see text] The binding processes of two Polo-like kinase inhibitors, RO3280 and GSK461364, to the human serum albumin (HSA) protein as well as the protonation equilibria of both compounds have been studied combining absorbance and fluorescence spectroscopy experiments together with density fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Sainz, Jesús, Pacheco-Liñán, Pedro J., Ripoll, Consuelo, González-Fuentes, Joaquín, Albaladejo, José, Bravo, Iván, Garzón-Ruiz, Andrés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997069/
https://www.ncbi.nlm.nih.gov/pubmed/36812406
http://dx.doi.org/10.1021/acs.molpharmaceut.2c00849
_version_ 1784903183802302464
author Fernández-Sainz, Jesús
Pacheco-Liñán, Pedro J.
Ripoll, Consuelo
González-Fuentes, Joaquín
Albaladejo, José
Bravo, Iván
Garzón-Ruiz, Andrés
author_facet Fernández-Sainz, Jesús
Pacheco-Liñán, Pedro J.
Ripoll, Consuelo
González-Fuentes, Joaquín
Albaladejo, José
Bravo, Iván
Garzón-Ruiz, Andrés
author_sort Fernández-Sainz, Jesús
collection PubMed
description [Image: see text] The binding processes of two Polo-like kinase inhibitors, RO3280 and GSK461364, to the human serum albumin (HSA) protein as well as the protonation equilibria of both compounds have been studied combining absorbance and fluorescence spectroscopy experiments together with density functional theory calculations. We found that the charge states of RO3280 and GSK461364 are +2 and +1, respectively, at the physiological pH. Nevertheless, RO3280 binds to HSA in the charge state +1 prior to a deprotonation pre-equilibrium. Binding constants to site I of HSA of 2.23 × 10(6) and 8.80 × 10(4) M(–1) were determined for RO3280 and GSK461364, respectively, at 310 K. The binding processes of RO3280 and GSK461364 to HSA are entropy- and enthalpy-driven, respectively. The positive enthalpy found for the RO3280-HSA complex formation could be related to a proton pre-equilibrium of RO3280.
format Online
Article
Text
id pubmed-9997069
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-99970692023-03-10 Unusually High Affinity of the PLK Inhibitors RO3280 and GSK461364 to HSA and Its Possible Pharmacokinetic Implications Fernández-Sainz, Jesús Pacheco-Liñán, Pedro J. Ripoll, Consuelo González-Fuentes, Joaquín Albaladejo, José Bravo, Iván Garzón-Ruiz, Andrés Mol Pharm [Image: see text] The binding processes of two Polo-like kinase inhibitors, RO3280 and GSK461364, to the human serum albumin (HSA) protein as well as the protonation equilibria of both compounds have been studied combining absorbance and fluorescence spectroscopy experiments together with density functional theory calculations. We found that the charge states of RO3280 and GSK461364 are +2 and +1, respectively, at the physiological pH. Nevertheless, RO3280 binds to HSA in the charge state +1 prior to a deprotonation pre-equilibrium. Binding constants to site I of HSA of 2.23 × 10(6) and 8.80 × 10(4) M(–1) were determined for RO3280 and GSK461364, respectively, at 310 K. The binding processes of RO3280 and GSK461364 to HSA are entropy- and enthalpy-driven, respectively. The positive enthalpy found for the RO3280-HSA complex formation could be related to a proton pre-equilibrium of RO3280. American Chemical Society 2023-02-22 /pmc/articles/PMC9997069/ /pubmed/36812406 http://dx.doi.org/10.1021/acs.molpharmaceut.2c00849 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Fernández-Sainz, Jesús
Pacheco-Liñán, Pedro J.
Ripoll, Consuelo
González-Fuentes, Joaquín
Albaladejo, José
Bravo, Iván
Garzón-Ruiz, Andrés
Unusually High Affinity of the PLK Inhibitors RO3280 and GSK461364 to HSA and Its Possible Pharmacokinetic Implications
title Unusually High Affinity of the PLK Inhibitors RO3280 and GSK461364 to HSA and Its Possible Pharmacokinetic Implications
title_full Unusually High Affinity of the PLK Inhibitors RO3280 and GSK461364 to HSA and Its Possible Pharmacokinetic Implications
title_fullStr Unusually High Affinity of the PLK Inhibitors RO3280 and GSK461364 to HSA and Its Possible Pharmacokinetic Implications
title_full_unstemmed Unusually High Affinity of the PLK Inhibitors RO3280 and GSK461364 to HSA and Its Possible Pharmacokinetic Implications
title_short Unusually High Affinity of the PLK Inhibitors RO3280 and GSK461364 to HSA and Its Possible Pharmacokinetic Implications
title_sort unusually high affinity of the plk inhibitors ro3280 and gsk461364 to hsa and its possible pharmacokinetic implications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997069/
https://www.ncbi.nlm.nih.gov/pubmed/36812406
http://dx.doi.org/10.1021/acs.molpharmaceut.2c00849
work_keys_str_mv AT fernandezsainzjesus unusuallyhighaffinityoftheplkinhibitorsro3280andgsk461364tohsaanditspossiblepharmacokineticimplications
AT pachecolinanpedroj unusuallyhighaffinityoftheplkinhibitorsro3280andgsk461364tohsaanditspossiblepharmacokineticimplications
AT ripollconsuelo unusuallyhighaffinityoftheplkinhibitorsro3280andgsk461364tohsaanditspossiblepharmacokineticimplications
AT gonzalezfuentesjoaquin unusuallyhighaffinityoftheplkinhibitorsro3280andgsk461364tohsaanditspossiblepharmacokineticimplications
AT albaladejojose unusuallyhighaffinityoftheplkinhibitorsro3280andgsk461364tohsaanditspossiblepharmacokineticimplications
AT bravoivan unusuallyhighaffinityoftheplkinhibitorsro3280andgsk461364tohsaanditspossiblepharmacokineticimplications
AT garzonruizandres unusuallyhighaffinityoftheplkinhibitorsro3280andgsk461364tohsaanditspossiblepharmacokineticimplications